MassHealth changes to coverage and prior authorization of anti-obesity and GLP-1/GIP medications
Customize your policy alerts
Sign up for all harvard pilgrim health care policy alerts
Know when harvard pilgrim health care releases new policies or updates existing guidance.
Monitor payer policy activity
Notifies payers/providers that MassHealth will stop covering drugs used for obesity/overweight effective July 1, 2026, describes which agents are affected, exceptions for certain medically accepted indications, and prior authorization (PA) handling and timelines.
MassHealth will no longer cover drugs used for the treatment of obesity or overweight effective July 1, 2026; listed agents will not be covered for weight loss.
GLP-1/GIP agents will remain coverable beyond June 30, 2026 only for specified medically accepted indications (MACE risk reduction, MASH, moderate-severe OSA) with documentation and approved PA.
PAs submitted between Feb 17, 2026 and June 30, 2026 for weight-loss indications will be reviewed but, if approved for obesity/overweight without documented comorbidities, will expire June 30, 2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.